Peter Donnelly is the founder of Genomics. Latest round: Series B. Backed by F-Prime Capital, Oxford Sciences Innovation, Foresite Capital.
Sir Peter Donnelly is the CEO and Co-Founder of Genomics plc, a genome analytics company that uses genetic data and algorithms to aid drug discovery and validate drug targets. He transitioned from academia after serving as Director of the Wellcome Trust Centre for Human Genetics and Professor of Statistical Science at the University of Oxford. His company has received funding from notable investors.
Full founder directory · Investor directory · Company funding database · Fundraising library